Hojin Kim
Papers
1
Total Citations
8
H-Index
1
About
Dr. Hojin Kim is a leading researcher in radiation oncology, with a primary focus on breast cancer treatment and the optimization of radiotherapy techniques. Her most notable work centers on stereotactic accelerated partial breast irradiation (SAPBI), a targeted approach that reduces radiation exposure to healthy tissues. In her highly cited 2023 prospective cohort study, Dr. Kim demonstrated that SAPBI achieves excellent cosmetic outcomes and low toxicity in early-stage breast cancer patients, offering a compelling alternative to whole-breast irradiation. This work, garnering 8 citations in a short time, has significant implications for improving patient quality of life and treatment precision. Her research bridges the gap between advanced radiation technology and patient-centered care, contributing to the broader goal of de-escalating therapy without compromising efficacy. Dr. Kim’s contributions are pivotal for clinicians and researchers seeking to refine breast cancer management, and her findings are increasingly referenced in guidelines for partial breast irradiation.
Research Focus
Key Achievements
Top Papers
- 1